ImpediMed Past Performance
Past criteria checks 0/6
ImpediMed has been growing earnings at an average annual rate of 7.7%, while the Medical Equipment industry saw earnings growing at 4.7% annually. Revenues have been growing at an average rate of 24.8% per year.
Key information
7.7%
Earnings growth rate
40.3%
EPS growth rate
| Medical Equipment Industry Growth | 4.7% |
| Revenue growth rate | 24.8% |
| Return on equity | -53.5% |
| Net Margin | -196.8% |
| Last Earnings Update | 31 Dec 2022 |
Recent past performance updates
Recent updates
We Think ImpediMed (ASX:IPD) Needs To Drive Business Growth Carefully
Mar 27
Here's Why We're Not Too Worried About ImpediMed's (ASX:IPD) Cash Burn Situation
Sep 28We're Not Worried About ImpediMed's (ASX:IPD) Cash Burn
Jun 10A Look At The Fair Value Of ImpediMed Limited (ASX:IPD)
Feb 01We Think ImpediMed (ASX:IPD) Can Afford To Drive Business Growth
Aug 25Here's Why We're Not Too Worried About ImpediMed's (ASX:IPD) Cash Burn Situation
Apr 06Analysts Expect Breakeven For ImpediMed Limited (ASX:IPD) Before Long
Feb 12
ImpediMed's (ASX:IPD) Stock Price Has Reduced 88% In The Past Five Years
Jan 08How Does ImpediMed's (ASX:IPD) CEO Salary Compare to Peers?
Nov 25Earnings and Revenue History
Quality Earnings: IPD is currently unprofitable.
Growing Profit Margin: IPD is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: IPD is unprofitable, but has reduced losses over the past 5 years at a rate of 7.7% per year.
Accelerating Growth: Unable to compare IPD's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: IPD is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-6.9%).
Return on Equity
High ROE: IPD has a negative Return on Equity (-53.46%), as it is currently unprofitable.